SEP
WGS icon

Signature Equity Partners’s GeneDx Holdings WGS Stock Holding History

Signature Equity Partners’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.55K Hold
110
– – ﹤0.01% 895
2026
Q1 		$7.06K Hold
110
– – ﹤0.01% 889
2025
Q4 		$14.3K Buy
+110
New +$15.1K 0.01% 741

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Signature Equity Partners's WGS Position: Q2 2026 in Review

Signature Equity Partners held its GeneDx Holdings (WGS) position steady in Q2 2026 at 110 shares worth $7.55K. The position accounts for ﹤0.01% of the portfolio, ranked #895.

Signature Equity Partners first reported a position in WGS in Q4 2025 and has held it in 3 quarters since. The position peaked at $14.3K in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Signature Equity Partners held 110 shares of GeneDx Holdings worth $7.55K as of Q2 2026.
  • Signature Equity Partners left its GeneDx Holdings share count unchanged in Q2 2026.
  • GeneDx Holdings made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #895 holding.
  • Signature Equity Partners first reported a position in GeneDx Holdings in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's GeneDx Holdings position peaked at $14.3K in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.